|
Section 330.1
|
Pregnancy-nursing warning |
|
Section 330.2
|
Imprinting of solid oral dosage form drug products |
|
Section 330.3
|
Drug categories |
|
Section 330.5
|
Procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded, and for |
|
Section 330.10
|
NDA deviations from applicable monograph |
|
Section 330.11
|
Status of over-the-counter (OTC) drugs previously reviewed under the Drug Efficacy Study (DESI) |
|
Section 330.12
|
Conditions for marketing ingredients recommended for over-the-counter (OTC) use under the OTC drug review |
|
Section 330.13
|
Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded |
|
Section 330.14
|
Scope |